These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6335369)

  • 21. Fragile X syndrome.
    Laxova R
    Adv Pediatr; 1994; 41():305-42. PubMed ID: 7992687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mental retardation with X fragility: Armenfrax. Review and personal studies].
    Engel E
    Rev Med Suisse Romande; 1983 Apr; 103(4):333-44. PubMed ID: 6348915
    [No Abstract]   [Full Text] [Related]  

  • 23. Folic acid metabolism in a patient with fragile X.
    Brøndum Nielsen K; Tommerup N; Friis B; Hjelt K; Hippe E
    Clin Genet; 1983 Sep; 24(3):153-5. PubMed ID: 6627717
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotics containing trimethoprim and the fragile X chromosome.
    Hecht F; Glover TW
    N Engl J Med; 1983 Feb; 308(5):285-6. PubMed ID: 6848950
    [No Abstract]   [Full Text] [Related]  

  • 25. [Encephalopathies tied to a fragility of the X chromosome].
    Fabre JM
    Soins Psychiatr; 1985 Oct; (60):17-20. PubMed ID: 3853898
    [No Abstract]   [Full Text] [Related]  

  • 26. Dilantin and the fragile X syndrome.
    Hagerman RJ; Levitas A
    N Engl J Med; 1983 Jun; 308(23):1424. PubMed ID: 6843639
    [No Abstract]   [Full Text] [Related]  

  • 27. Fragile-X syndrome: diagnosis and research.
    Madison LS; Mosher GA; George CH
    J Pediatr Psychol; 1986 Mar; 11(1):91-102. PubMed ID: 3514835
    [No Abstract]   [Full Text] [Related]  

  • 28. Fragile X-syndrome: literature review and report of two cases.
    Ridaura-Ruiz L; Quinteros-Borgarello M; Berini-Aytés L; Gay-Escoda C
    Med Oral Patol Oral Cir Bucal; 2009 Sep; 14(9):e434-9. PubMed ID: 19718005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fragile X syndrome: history, diagnosis, and treatment.
    Hagerman RJ; McBogg P; Hagerman PJ
    J Dev Behav Pediatr; 1983 Jun; 4(2):122-30. PubMed ID: 6348096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile-X syndrome in Hawaii: a summary of clinical experience.
    Rhoads FA
    Am J Med Genet; 1984 Jan; 17(1):209-14. PubMed ID: 6711596
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of fragile-X.
    Harpey JP
    Pediatrics; 1982 May; 69(5):670. PubMed ID: 6979030
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful prenatal diagnosis of the fragile X chromosome without the use of folic acid antagonists].
    Macek M; Nedomová V; Bavorová H; Loucková M; Chudoba D; Seemanová E; Schmidtová A; Passarge E
    Cesk Pediatr; 1983 Sep; 38(9):525-7. PubMed ID: 6640753
    [No Abstract]   [Full Text] [Related]  

  • 33. Fragile X-linked mental retardation of macro-orchidism.
    Moore BC; Glover TW; Kaiser-McCaw B; Hecht F
    West J Med; 1982 Oct; 137(4):278-81. PubMed ID: 7179944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fragile X syndrome II: preliminary data on growth and development in males.
    Partington MW
    Am J Med Genet; 1984 Jan; 17(1):175-94. PubMed ID: 6711594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled study of longitudinal IQ changes in females and males with fragile X syndrome.
    Wright-Talamante C; Cheema A; Riddle JE; Luckey DW; Taylor AK; Hagerman RJ
    Am J Med Genet; 1996 Aug; 64(2):350-5. PubMed ID: 8844079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Variations in the presence of a fragile site on X--fra(X)--according to cases and methods used].
    Crippa L; Delozier-Blanchet CD; Engel E
    J Genet Hum; 1984 Jul; 32(3):193-7. PubMed ID: 6481341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome.
    Berry-Kravis E; Sumis A; Hervey C; Nelson M; Porges SW; Weng N; Weiler IJ; Greenough WT
    J Dev Behav Pediatr; 2008 Aug; 29(4):293-302. PubMed ID: 18698192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Homocystinuria: effectiveness of the treatment with pyridoxine, folic acid, and betaine].
    Montero Brens C; Dalmau Serra J; Cabello Tomás ML; García Gómez AM; Rodes Monegal M; Vilaseca Busca A
    An Esp Pediatr; 1993 Jul; 39(1):37-41. PubMed ID: 8363149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is fragile X syndrome a pervasive developmental disability? Cognitive ability and adaptive behavior in males with the full mutation.
    Fisch GS; Holden JJ; Simensen R; Carpenter N; Howard-Peebles PN; Maddalena A; Sandgrund A; Jacques JR; McGann B
    Am J Med Genet; 1994 Jul; 51(4):346-52. PubMed ID: 7942997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximizing the sensitivity of a screening questionnaire for determining Fragile X at-risk status.
    Teisl JT; Reiss AL; Mazzocco MM
    Am J Med Genet; 1999 Apr; 83(4):281-5. PubMed ID: 10208162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.